AKIPRESS.COM - The Russian Direct Investment Fund, sovereign wealth fund, announced the registration of the Russian Sputnik V vaccine against coronavirus by the Ministry of Health of Mongolia.

The vaccine was approved under the emergency use authorization procedure without additional clinical trials in the country. The EUA was obtained with the assistance from RDIF's local partner Mongol Emimpex Concern LLC, the country's leading pharmaceutical company.

Mongolia has become the 23rd country in the world to approve Sputnik V. The vaccine had been approved earlier in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, UAE, Iran, Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (entity of Bosnia and Herzegovina), Lebanon, Myanmar and Pakistan.